New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Wagistrasse 27
- Schlieren , 8952
InSphero is a leading supplier of organotypic in vitro 3D microtissues and 3D focused contract research services, enabling more biologically relevant, highly predictive toxicology and drug efficacy testing. InSphero’s complete range of solutions for 3D cell culture workflows also includes assay kits, culture media, spheroid imaging equipment, and GravityPLUS™ hanging drop culture plates. The company, headquartered in Switzerland, with subsidiaries in the USA and in Germany, currently counts all of the top fifteen global pharmaceutical and cosmetics companies as customers. InSphero is certified to the ISO 9001:2008 standard for its Quality Management System.